The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin

Oncogene

Volumn 24, Issue 35, 2005, Pages 5525-5532

  Zeisig, Deniz T ^a   Bittner, Claudia B ^a   Zeisig, Bernd B ^a   García Cuéllar, Maria Paz ^a   Hess, Jay L ^b   Slany, Robert K ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chromatin; ENL; Histone; Leukemia; MLL

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN; DNA BINDING PROTEIN; HISTONE; HYBRID PROTEIN; MLL PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; CHROMATIN; CONTROLLED STUDY; GENE FUSION; GENE OVEREXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; ANIMAL; CHEMISTRY; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS; PROTO ONCOGENE; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION; TWO HYBRID SYSTEM;

ANIMALS; CHROMATIN; DNA-BINDING PROTEINS; HISTONES; HUMANS; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENES; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 24644514410     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208699     Document Type: Article

References (40)

1. Ayton PM and Cleary ML. (2001). Oncogene, 20, 5695-5707.
2. Bittner CB, Zeisig DT, Zeisig BB and Slany RK. (2004). Eukaryot. Cell, 3, 976-983.
3. Cairns BR, Henry NL and Komberg RD. (1996). Mol. Cell. Biol., 16, 3308-3316.
4. Debernardi S, Bassini A, Jones LK, Chaplin T, Linder B, de Bruijn DR, Meese E and Young BD. (2002). Blood, 99, 275-281.
5. Erfurth F, Hemenway CS, De Erkenez AC and Domer PH. (2004). Leukemia, 18, 92-102.
6. Ernst P, Wang J, Huang M, Goodman RH and Korsmeyer SJ. (2001). Mol. Cell. Biol., 21, 2249-2258.
7. Estable MC, Naghavi MH, Kato H, Xiao H, Qin J, Vahine A and Roeder RG. (2002). J. Biomed. Sci., 9, 234-245.
8. Feng Q, Wang H, Ng HH, Erdjument-Bromaee H, Tempst P, Struhi K and Zhang Y. (2002). Curr. Biol., 12, 1052-1058.
9. Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ and Look AT. (2003). Blood, 102, 262-268.
10. Garcia-Cuellar MP, Schreiner SA, Birke M, Hamacher M, Fey GH and Slany RK. (2000). Oncogene, 19, 1744-1751.
11. Garcia-Cuellar MP, Zilles O, Schreiner SA, Birke M, Winkler TH and Slany RK. (2001). Oncogene, 20, 411-419.
12. Hess JL. (2004). Trends Mol. Med., 10, 500-507.
13. Krogan NJ, Dover J, Wood A, Schneider J, Heidt J, Boateng MA, Dean K, Ryan OW, Golshani A, Johnston M, Greenblatt JF and Shilatifard A. (2003). Mol. Cell, 11, 721-729.
14. Le Masson I, Yu DY, Jensen K, Chevalier A, Courbeyrette R, Boulard Y, Smith MM and Mann C. (2003). Mol. Cell. Biol., 23, 6086-6102.
15. Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, Gibbs D, Brock HW, Slany R and Hess JL. (2003). Cancer Cell, 4, 197-207.
16. Meijsing SH and Ehrenhofer-Murray AE. (2001). Genes Dev., 15, 3169-3182.
17. Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, Allis CD and Hess JL. (2002). Mol. Cell, 10, 1107-1117.
18. Milne TA, Martin ME, Brock HW, Slany RK and Hess JL. (2005). Cancer Res., submitted.
19. Nakamura T, Mon T, Tada S, Krajewski W, Rozovskaia T, Wassell R, Dubois G, Mazo A, Croce CM and Canaani E. (2002). Mol. Cell, 10, 1119-1128.
20. Nilson I, Reichel M, Ennas MG, Greim R, Knorr C, Siegler G, Greil J, Fey GH and Marschalek R. (1997). Br. J. Haematol., 98, 157-169.
21. Petruk S, Sedkov Y, Smith S, Tillib S, Kraevski V, Nakamura T, Canaani E, Croce CM and Mazo A. (2001). Science, 294, 1331-1334.
22. Ross ME, Zhou X, Song G, Shurtleff SA, Girtman K, Williams WK, Liu HC, Mahfouz R, Raimondi SC, Lenny N, Patel A and Downing JR. (2003). Blood, 102, 2951-2959.
23. Rozenblatt-Rosen O, Rozovskaia T, Burakov D, Sedkov Y, Tillib S, Blechman J, Nakamura T, Croce CM, Mazo A and Canaani E. (1998). Proc. Natl. Acad. Sci. USA, 95, 4152-4157.
24. Rozovskaia T, Feinstein E, Mor O, Foa R, Blechman J, Nakamura T, Croce CM, Cimino G and Canaani E. (2001). Oncogene, 20, 874-878.
25. Schreiner S, Birke M, Garcia-Cuellar MP, Zilles O, Greil J and Slany RK. (2001). Cancer Res., 61, 6480-6486.
26. Shilatifard A, Lane WS, Jackson KW, Conaway RC and Conaway JW. (1996). Science, 271, 1873-1876.
27. Slany RK, Lavau C and Cleary ML. (1998). Mol. Cell. Biol., 18, 122-129.
28. So CW and Cleary ML. (2002). Mol. Cell. Biol., 22, 6542-6552.
29. So CW and Cleary ML. (2003). Blood, 101, 633-639.
30. So CW and Cleary ML. (2004). Blood, 104, 919-922.
31. So CW, Lin M, Ayton PM, Chen EH and Cleary ML. (2003). Cancer Cell, 4, 99-110.
32. Srinivasan RS, Nesbit JB, Marrero L, Erfurth F, LaRussa VF and Hemenway CS. (2004). Leukemia, 18, 1364-1372.
33. Sutton A, Shia WJ, Band D, Kaufman PD, Osada S, Workman JL and Sternglanz R. (2003). J. Biol. Chem., 278, 16887-16892.
34. Wood A, Schneider J, Dover J, Johnston M and Shilatifard A. (2003). J. Biol. Chem., 278, 34739-34742.
35. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L and Downing JR. (2002). Cancer Cell, 1, 133-143.
36. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W and Cleary ML. (2004). Mol. Cell. Biol., 24, 5639-5649.
37. Zeisig BB, Garcia-Cuellar MP, Winkler TH and Slany RK. (2003a). Oncogene, 22, 1629-1637.
38. Zeisig BB, Milne T, Garcia-Cuellar MP, Schreiner S, Martin ME, Fuchs U, Borkhardt A, Chanda SK, Walker J, Soden R, Hess JL and Slany RK. (2004). Mol. Cell. Biol., 24, 617-628.
39. Zeisig BB, Schreiner S, Garcia-Cuellar MP and Slany RK. (2003b). Leukemia, 17, 359-365.
40. Zhang H, Richardson DO, Roberts DN, Utley R, Erdjument-Bromage H, Tempst P, Cote J and Cairns BR. (2004). Mol. Cell. Biol., 24, 9424-9436.